GlassScriptPhysician profile
Karl D Schultz
NPI 1558344507
$47,274.64
in general payments reported to CMS, 2019-2025
40 companies · $1,742 in 2025
The $1,742 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $10K · 2020: $1,720 · 2021: $925 · 2022: $534 · 2023: $22K · 2024: $10K · 2025: $1,742.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $22K · Travel and Lodging: $9,009 · Food and Beverage: $2,614 · Education: $39.52.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $22,214.70 |
| Travel and Lodging | $9,009.22 |
| Food and Beverage | $2,614.06 |
| Education | $39.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spineology INC. | $30,339.06 | 2019-2024 | Optimesh Expandable Interbody Fusion System |
| Medacta USA, INC. | $8,834.40 | 2024-2025 | Must, Myspine |
| Nuvasive, INC. | $3,549.14 | 2019 | |
| Globus Medical, INC. | $1,161.19 | 2025 | Excelsius Gps, Senza |
| Spine Wave, INC. | $310.64 | 2022-2025 | Proficient Posterior Cervical Spine System, Spinal Implant, Velocity Expandable Interbody System |
| Centinel Spine, LLC | $235.21 | 2023-2024 | Prodisc L |
| Aesculap Implant Systems, LLC | $223.32 | 2019-2020 | |
| Medtronic, INC. | $218.73 | 2021-2025 | O-Arm, Intellis Adaptivestim, Inceptiv |
| Si-Bone, INC. | $192.14 | 2019-2024 | |
| Cerapedics INC. | $161.24 | 2024 | I-Factor Peptide Enhanced Bone Graft |
| Xtant Medical INC | $154.77 | 2022-2025 | |
| Intrinsic Therapeutics | $143.40 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $141.51 | 2023-2025 | Andexxa, Airsupra |
| Medical Device Business Services, INC. | $137.01 | 2022 | |
| Icotec Medical INC. | $127.50 | 2021 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nexxt Spine LLC | $125.19 | 2021 | |
| Ethicon US, LLC | $112.82 | 2022 | |
| Nevro Corp. | $108.05 | 2022-2024 | Senza |
| Spineguard, INC. | $100.00 | 2024 | |
| Stryker Corporation | $88.00 | 2023-2024 | N/A, Avs Navigator |
| Sanara Medtech INC. | $86.40 | 2020 | |
| Orthofix Medical, INC. | $83.83 | 2020 | |
| Brainlab, INC. | $80.00 | 2020 | |
| Depuy Synthes Sales INC. | $78.09 | 2020-2025 | Matrixneuro |
| Abbott Laboratories | $77.98 | 2021-2023 | Freestyle Libre 2 |
| Radius Health, INC. | $69.40 | 2020-2024 | Tymlos |
| Boston Scientific Corporation | $68.16 | 2019-2025 | Intracept |
| Surgalign Spine Technologies, INC. | $32.00 | 2019 | |
| Life Spine, INC. | $30.63 | 2020 | |
| Medtronic USA, INC. | $29.65 | 2020 | |
| Kyocera Medical Technologies, INC. | $23.16 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $21.22 | 2023 | Iovera, Zilretta, Exparel |
| Azurity Pharmaceuticals, INC. | $20.60 | 2023 | Gliadel |
| Lilly USA, LLC | $20.08 | 2023 | |
| Portola Pharmaceuticals, LLC | $19.70 | 2019 | |
| Ethicon INC. | $17.33 | 2019 | |
| Olympus America INC. | $14.85 | 2021 | |
| Smith+Nephew, INC. | $13.63 | 2025 | Pico 14, Renasys Touch |
| Baxter Healthcare | $13.43 | 2024 | Floseal |
| Arbor Pharmaceuticals, INC. | $11.18 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1,530,637.45 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karl Schultz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.